Authors
Latest:
Low and Maldonado on Leveraging Wearable Devices to Improve Inpatient AmbulationSarah Low RN, MSN, OCN, CMSRN; and Claudia Maldonado-Howell, RN, MSN, FNP, BS, CMSRN, discuss their research on wearable technology.
Latest:
Oncology Drug Crash Course: Fam-Trastuzumab Deruxtecan-Nxki (Enhertu)After demonstrating significant efficacy as a third-line treatment for patients with metastatic HER2-positive breast cancer, fam-trastuzumab deruxtecan-nxki has gained approval from the FDA for 5 indications and is under investigation across solid tumors.
Latest:
Menstrual Suppression Is a Valuable Component of HSCT Care for Premenopausal WomenMenstrual suppression can improve outcomes and quality of life in premenopausal women undergoing hematopoietic stem cell transplant.
Latest:
Oncology Drug Crash Course: Fam-Trastuzumab Deruxtecan-Nxki (Enhertu)After demonstrating significant efficacy as a third-line treatment for patients with metastatic HER2-positive breast cancer, fam-trastuzumab deruxtecan-nxki has gained approval from the FDA for 5 indications and is under investigation across solid tumors.
Latest:
Difficulty of Genomic Testing Conversations Highlights Need for EducationDanielle Fournier, DNP, APRN, AGPCNP-BC, AOCNP, discusses the role of oncology nurses in genomic testing.
Latest:
Insights on Evolving Treatment Strategies for Multiple MyelomaThe panel provides key takeaways on the most impactful innovations shaping the future of multiple myeloma treatment.
Latest:
Adjuvant Mitotane Misses RFS End Point in Adrenocortical CarcinomaAdjuvant mitotane did not yield a significantly reduced risk of recurrence among patients with adrenocortical carcinoma.
Latest:
Normalize the Clinical Trial Conversation"Clinical trials are the vital bridge between research and a drug’s eventual availability to patients."
Latest:
The Road Ahead: Future Directions in Metastatic Melanoma TreatmentPanelists discuss the importance of effective communication and multidisciplinary collaboration in managing immunotherapy toxicities and ensuring seamless patient care, while highlighting promising advances in melanoma treatment and the role of telehealth and community outreach in expanding access and improving outcomes.
Latest:
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical CannabisAlyssa Ridad BSN-RN, OCN; and Amanda McKaig, BSN, RN, OCN, discuss oncology nurse perceptions of medical cannabis.
Latest:
With Personalized Cancer Vaccines On the Horizon, What Is Nurses’ Role?Nurses and APPs provide an essential link between physicians and patients when facilitating and monitoring outcomes with personalized cancer vaccines.
Latest:
MPN-Associated Anemia: What Nurses Should Look Out ForOncology nurses should have open communication with patients and closely monitor their hemoglobin levels when dealing with patients with myelofibrosis who have or may have anemia.
Latest:
Rx Road Map: Subcutaneous Daratumumab in Multiple MyelomaA registered nurse gives best practices for use of subcutaneous daratumumab in multiple myeloma.
Latest:
Patient Experience Programs Improve Overall Quality of CarePatient experience programs can improve quality of care and decrease organization costs, resulting in a more efficient and less expensive cancer care journey for patients.
Latest:
Advice for New Nurse Practitioners Working With Patients With Endometrial CancerClosing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Latest:
Life After CAR T Therapy: Insights for Patients and Referring OncologistsThis video segment focuses on key elements of patient education and support for long-term CAR-T survivors, strategies to maintain quality of life and manage late effects, differences in supportive care needs between ide-cel and cilta-cel recipients, and approaches to fostering collaboration between academic centers and community practices for optimal long-term care.
Latest:
VCU Massey Cancer Center achieves comprehensive status from the National Cancer InstituteVCU Massey Cancer Center has been designated a Comprehensive Cancer Center by the National Cancer Institute (NCI), the nation’s principal authority on cancer research and training.
Latest:
Approvals in Cancer Care Call for Multidisciplinary CooperationWorking with multidisciplinary teams and educating patients are key to treating patients with cancer while navigating newly approved treatments.
Latest:
Innovative Program Reduces Nurse Turnover and Fosters DevelopmentThe US Oncology Network (The Network) has developed one of the most comprehensive programs in the nation to support the professional development and retention of new oncology nurses.
Latest:
CAR T-Cell Therapy May Be Moving Up in Myeloma Treatment SequencingCAR T-cell therapy is starting to enter treatment conversations sooner with patients with multiple myeloma, according to Nick Barkemeyer, PA-C, MMS.
Latest:
Tepotinib Shows Manageable Safety in MET Exon 14+ NSCLCTepotinib was associated with frequent but manageable adverse events in MET exon 14–positive NSCLC, with peripheral edema most common.
Latest:
GLP-1a Associated With Better Outcomes for Those With Polycythemia VeraMortality, progression, and venous thromboembolism were among outcomes improved for patients with polycythemia vera taking a GLP-1a.
Latest:
Advice for New Nurse Practitioners Working With Patients With Endometrial CancerClosing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Latest:
Patient Education, Shared Decision-Making, and Optimizing Care for ESR1-Mutated Breast CancerPanelists discuss how a multidisciplinary team approach to patient education and medication management is crucial for ensuring adherence and optimal outcomes with oral medications like elacestrant.
Latest:
Recipe For DisasterAn oncology social worker reflects on a day in the life and how the memory of her sister motivates her to tackle her work.
Latest:
Psychological Concerns in the Aftermath of a Breast Cancer Diagnosis and Treatment for Young AdultsReceiving a breast cancer diagnosis and undergoing treatment as a young adult takes a physical and emotional toll.
Latest:
Oncology Nurses Can Help Better Prevent Chronic Lymphedema With BIS TechnologySheila Ridner, PhD, RN, FAAN, discusses the implications of the PREVENT study and how oncology nurses can advocate for patients with breast cancer.
Latest:
Research Provides Learning Opportunities for Oncology NursesOncology nurses are needed in research roles, which can provide experience with new therapies, explained Josh Settlemire, MSN, RN, OCN.
